Skip to main navigation Skip to search Skip to main content

Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Co-occurrence of posttraumatic stress disorder (PTSD) and substance use disorders (SUDs) is common and concurrent treatment is recommended. Relatively little is known about which evidence-based psychotherapies for PTSD are most effective for patients with varying substance use profiles. We aim to examine the comparative effectiveness of trauma-focused therapy (TFT) and non-trauma-focused therapy (NTFT) among Veterans with PTSD and SUD. TFT has been found to be effective among those with PTSD/SUD, though effects are smaller and rates of treatment non-completion are higher than in those without SUD. NTFTs suggested for the treatment of PTSD, such as Present Centered Therapy, (PCT) have not been examined among those with co-occurring SUD, despite lower rates of treatment dropout. We will also examine the comparative effectiveness of TFT and NTFT for patients with varying SUD severity, type of substances used, and patient treatment preference. Method: 420 Veterans with PTSD and SUD will be randomized in a prospective, pragmatic comparative effectiveness trial at 14 Veterans Health Administration facilities. Participants will receive either TFT (Prolonged Exposure or Cognitive Processing Therapy) or NTFT (PCT) after enrolling in concurrent SUD treatment-as-usual. Assessments will occur at baseline, posttreatment, 3- and 6 -months posttreatment. Main outcomes are PTSD symptom severity and PTSD treatment dropout. Clinician, patient, and leadership stakeholder panels advise study activities, and a process evaluation will identify strategies to enhance the implementation of evidence-based PTSD treatments in SUD care settings. Conclusions: Results will provide critical information to guide clinicians when recommending PTSD treatments to patients with comorbid SUD. ClinicalTrials.gov Identifier: NCT04581434.

Original languageEnglish (US)
Article number106876
JournalContemporary Clinical Trials
Volume120
DOIs
StatePublished - Sep 2022

Bibliographical note

Funding Information:
Research reported in this publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (PTSD-2019C1-16009). The statements in this publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee. The funder had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. This material is the result of work supported with resources and the use of facilities at the Minneapolis VA Healthcare System, Minneapolis MN. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. No authors declared no competing interests associated with this publication. We thank Sean Nugent, Ann Bangerter, Andrea Cutting, Rose Degerstrom, and Brent Taylor for their assistance with this project.

Funding Information:
Research reported in this publication was funded through a Patient-Centered Outcomes Research Institute (PCORI) Award ( PTSD-2019C1-16009 ). The statements in this publication are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee . The funder had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. This material is the result of work supported with resources and the use of facilities at the Minneapolis VA Healthcare System, Minneapolis MN. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. No authors declared no competing interests associated with this publication. We thank Sean Nugent, Ann Bangerter, Andrea Cutting, Rose Degerstrom, and Brent Taylor for their assistance with this project.

Publisher Copyright:
© 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being
  2. SDG 16 - Peace, Justice and Strong Institutions
    SDG 16 Peace, Justice and Strong Institutions

Keywords

  • Posttraumatic stress disorder
  • Psychotherapy
  • Randomized clinical trial
  • Stakeholder engagement
  • Substance use disorders

Fingerprint

Dive into the research topics of 'Comparative effectiveness of trauma-focused and non-trauma-focused psychotherapy for PTSD among veterans with comorbid substance use disorders: Protocol & rationale for a randomized clinical trial'. Together they form a unique fingerprint.

Cite this